38853763|t|Association of APOE genotype and cerebrospinal fluid Abeta and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.
38853763|a|OBJECTIVE: Little is known about amyotrophic lateral sclerosis (ALS)-nonspecific cognitive deficits - most notably memory disturbance - and their biological underpinnings. We investigated the associations of the Alzheimer's disease (AD) genetic risk factor APOE and cerebrospinal fluid (CSF) biomarkers Abeta and tau proteins with cognitive and motor phenotype in ALS. METHODS: APOE haplotype was determined in 281 ALS patients; for 105 of these, CSF levels of Abeta42, Abeta40, total tau (T-tau), and phosphorylated tau (P-tau181) were quantified by chemiluminescence enzyme immunoassay (CLEIA). The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was employed to evaluate the neuropsychological phenotype. RESULTS: APOE-E4 allele was associated with worse ECAS memory score (median, 14.0 in carriers vs. 16.0 in non-carriers) and lower CSF Abeta42 (-0.8 vs. 0.1, log-transformed values) and Abeta42/40 ratio (-0.1 vs. 0.3). Some 37.1% of ALS patients showed low Abeta42 levels, possibly reflecting cerebral Abeta deposition. While lower Abeta42/40 correlated with lower memory score (beta = 0.20), Abeta42 positively correlated with both ALS-specific (beta = 0.24) and ALS-nonspecific (beta = 0.24) scores. Although Abeta42/40 negatively correlated with T-tau (beta = -0.29) and P-tau181 (beta = -0.33), we found an unexpected positive association of Abeta42 and Abeta40 with both tau proteins. Regarding motor phenotype, lower levels of Abeta species were associated with lower motor neuron (LMN) signs (Abeta40: beta = 0.34; Abeta42: beta = 0.22). CONCLUSIONS: APOE haplotype and CSF Abeta biomarkers are associated with cognitive deficits in ALS and particularly with memory impairment. This might partly reflect AD-like pathophysiological processes, but additional ALS-specific mechanisms could be involved.
38853763	15	19	APOE	Gene	348
38853763	53	58	Abeta	Gene	351
38853763	63	66	tau	Gene	4137
38853763	116	145	amyotrophic lateral sclerosis	Disease	MESH:D000690
38853763	180	209	amyotrophic lateral sclerosis	Disease	MESH:D000690
38853763	211	214	ALS	Disease	MESH:D000690
38853763	228	246	cognitive deficits	Disease	MESH:D003072
38853763	262	280	memory disturbance	Disease	MESH:D008569
38853763	359	378	Alzheimer's disease	Disease	MESH:D000544
38853763	380	382	AD	Disease	MESH:D000544
38853763	404	408	APOE	Gene	348
38853763	450	455	Abeta	Gene	351
38853763	460	463	tau	Gene	4137
38853763	511	514	ALS	Disease	MESH:D000690
38853763	525	529	APOE	Gene	348
38853763	562	565	ALS	Disease	MESH:D000690
38853763	566	574	patients	Species	9606
38853763	608	615	Abeta42	Gene	351
38853763	632	635	tau	Gene	4137
38853763	639	642	tau	Gene	4137
38853763	664	667	tau	Gene	4137
38853763	784	787	ALS	Disease	MESH:D000690
38853763	870	874	APOE	Gene	348
38853763	995	1002	Abeta42	Gene	351
38853763	1093	1096	ALS	Disease	MESH:D000690
38853763	1097	1105	patients	Species	9606
38853763	1117	1124	Abeta42	Gene	351
38853763	1162	1167	Abeta	Gene	351
38853763	1253	1260	Abeta42	Gene	351
38853763	1293	1296	ALS	Disease	MESH:D000690
38853763	1324	1327	ALS	Disease	MESH:D000690
38853763	1411	1414	tau	Gene	4137
38853763	1506	1513	Abeta42	Gene	351
38853763	1536	1539	tau	Gene	4137
38853763	1593	1598	Abeta	Gene	351
38853763	1682	1689	Abeta42	Gene	351
38853763	1718	1722	APOE	Gene	348
38853763	1741	1746	Abeta	Gene	351
38853763	1778	1796	cognitive deficits	Disease	MESH:D003072
38853763	1800	1803	ALS	Disease	MESH:D000690
38853763	1826	1843	memory impairment	Disease	MESH:D008569
38853763	1871	1873	AD	Disease	MESH:D000544
38853763	1924	1927	ALS	Disease	MESH:D000690
38853763	Association	MESH:D008569	348
38853763	Negative_Correlation	348	351
38853763	Association	MESH:D003072	348
38853763	Association	MESH:D000690	351

